M. Toi
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 3
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
- PARP inhibition in cancer therapy 1
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Katsumasa Kuroi (3 shared papers)Chie Tanaka (1 shared paper)Masafumi Kurosumi (1 shared paper)Shohei Nakamura (1 shared paper)Nobuaki Sato (1 shared paper)Hitoshi Tsuda (1 shared paper)N Masuda (1 shared paper)Yasuo Ohashi (1 shared paper)
- Journals
- International Journal of Oncology (1 paper)European Journal of Cancer (1 paper)Breast Cancer (1 paper)Japanese Journal of Clinical Oncology (1 paper)PubMed (1 paper)
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
M. Toi
5 papers receiving 103 citations
Peers
Comparison fields: 5 of 26
- Cancer Research 37
- Oncology 25
- Pulmonary and Respiratory Medicine 17
- Molecular Biology 32
- Pathology and Forensic Medicine 6
Countries citing papers authored by M. Toi
This map shows the geographic impact of M. Toi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Toi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Toi more than expected).
Fields of papers citing papers by M. Toi
This network shows the impact of papers produced by M. Toi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Toi. The network helps show where M. Toi may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Toi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 47 | |
| 2 | 2001 | 44 | |
| 3 | 2019 | 11 | |
| 4 | [Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline]. | 1999 | 3 |
| 5 | 2018 | 1 |
About M. Toi
M. Toi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Dermatology and Cancer Research, having authored 5 papers that have together received 106 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), RNA modifications and cancer (1 paper), Chemotherapy-related skin toxicity (1 paper) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Cancer Research (37 citations), Oncology (25 citations), Pulmonary and Respiratory Medicine (17 citations), Molecular Biology (32 citations) and Pathology and Forensic Medicine (6 citations). M. Toi has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Katsumasa Kuroi, Chie Tanaka, Masafumi Kurosumi, Shohei Nakamura, Nobuaki Sato, Hitoshi Tsuda, N Masuda, Yasuo Ohashi, Norio Yamamoto and Yoshiko Umeyama. Their work appears in journals such as International Journal of Oncology, European Journal of Cancer, Breast Cancer, Japanese Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.